CytomX Therapeutics Inc Logo

CytomX Therapeutics Inc (CTMX): Eigentümerstruktur

Takani Score ?
41.7

Preis (11.09.2026)52W Hoch52W Tief
3,29 US Dollar8,21 US Dollar1,9 US Dollar
Analysten KonsensBuyOutperformHoldUnderperformSell
12,25 US Dollar23100
Externe Analystenschätzungen (Quelle: EODHD) – keine Anlageempfehlung von Takani.
#SharesShort [%]Short Ratio
217.899.28417,4512,96

Überblick
Finanzdaten
Fairen Wert selbst schätzen
Marktvergleich
Industrievergleich
Inhaber
Bilanzscores

Eigentümerstruktur

Analyse der Aktionärsstruktur und institutionellen Investoren

Unternehmensdaten

Grundlegende Informationen

Grunddaten

Name CytomX Therapeutics Inc
Mitarbeiter 69
Handelsplatz NASDAQ
Ticker Symbol CTMX
IPO Datum 2015-10-08
Adresse 151 Oyster Point Boulevard, South San Francisco, CA, United States, 94080
Webseite https://www.cytomx.com

Unternehmensführung

RangNamePosition
1Dr. Sean A. McCarthy DPHILChairman & CEO
2Mr. Christopher W. OgdenSVP, CFO & Secretary
3Ms. Rachael LesterChief Business Officer & Senior VP
4Dr. Marcia P. Belvin Ph.D.Senior VP & Chief Scientific Officer
5Ms. Alejandra Veronica Carvajal J.D.Chief Legal Officer
6Ms. Danielle Olander-MoghadassianSenior VP & Chief Human Resources Officer
7Ms. Leslie Robbins J.D.Senior Vice President of Intellectual Property
8Dr. Yu-Waye Chu M.D.Senior VP & Chief Medical Officer
9Ms. Dawn BensonSenior Vice President of Quality & Product Manufacturing
10Dr. Stephanie Robertson Ph.D.Senior Vice President of Alliances & Program Leadership

Aktionärsverteilung

Aufteilung der Investoren

Größte Investoren

RangInhaberAnteileWert
1FMR Inc14,67%105,13 Mio. USD
2Kynam Capital Management, LP9,96%71,40 Mio. USD
3Perceptive Advisors LLC4,79%34,35 Mio. USD
4Bank of America Corp4,68%33,57 Mio. USD
5VR Adviser, LLC4,58%32,84 Mio. USD
6Vanguard Capital Management, LLC4,01%28,73 Mio. USD
7Point72 Asset Management, L.P.3,61%25,91 Mio. USD
8State Street Corp2,60%18,63 Mio. USD
9BlackRock Inc2,40%17,20 Mio. USD
10Wellington Management Company LLP2,37%17,01 Mio. USD
11Baker Bros Advisors LP2,28%16,37 Mio. USD
12Elmind Capital LP2,09%14,97 Mio. USD
13Nextech Invest, Ltd.2,04%14,64 Mio. USD
14Marshall Wace Asset Management Ltd1,90%13,61 Mio. USD
15Two Sigma Investments LLC1,90%13,60 Mio. USD
16Eversept Partners, LP1,63%11,71 Mio. USD
17Siren, L.L.C.1,59%11,38 Mio. USD
18ADAR1 Capital Management LLC1,57%11,22 Mio. USD
19UBS Group AG1,43%10,27 Mio. USD
20Citadel Advisors Llc1,43%10,23 Mio. USD